Your browser doesn't support javascript.
loading
Does in-shoe pressure analysis to assess and modify medical grade footwear improve patient adherence and understanding? A mixed methods study.
McDonogh, Clare; Nube, Vanessa L; Frank, Georgina; Twigg, Stephen M; Penkala, Stefania; Holloway, Samantha; Snyder, Robert.
Affiliation
  • McDonogh C; Podiatry Department, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia. clare.mcdonogh@health.nsw.gov.au.
  • Nube VL; Diabetes Centre and Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia. clare.mcdonogh@health.nsw.gov.au.
  • Frank G; Podiatry Department, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia.
  • Twigg SM; Podiatry Department, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia.
  • Penkala S; Diabetes Centre and Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Holloway S; Central Clinical School, Faculty of Medicine and Health and The Charles Perkins Centre, University of Sydney, Sydney, Australia.
  • Snyder R; School of Health Sciences and Translational Health Research Institute, Western Sydney University, Sydney, Australia.
J Foot Ankle Res ; 15(1): 94, 2022 Dec 24.
Article in En | MEDLINE | ID: mdl-36564819
ABSTRACT

BACKGROUND:

Medical grade footwear (MGF) with demonstrated plantar-pressure reducing effect is recommended to reduce the risk of diabetes-related foot ulceration (DFU). Efficacy of MGF relies on high adherence (≥ 80%). In-shoe pressure analysis (IPA) is used to assess and modify MGF, however, there is limited evidence for the impact on patient adherence and understanding of MGF. The primary aim of this study was to determine if self-reported adherence to MGF usage in patients with previous DFU improved following IPA compared to adherence measured prior. The secondary aim was to determine if patient understanding of MGF improved following in-shoe pressure analysis.

METHODS:

Patients with previous DFU fitted with MGF in the last 12 months were recruited. The first three participants were included in a pilot study to test procedures and questionnaires. MGF was assessed and modified at Week 0 based on findings from IPA using the Pedar system (Novel). Patients completed two questionnaires, one assessing patient adherence to MGF at Week 0 and Week 4, the other assessing patient understanding of MGF before and after IPA at week 0. Patient understanding was measured using a 5-point Likert scale (strongly disagree 1 to strongly agree 5). Patient experience was assessed via a telephone questionnaire administered between Weeks 0-1.

RESULTS:

Fifteen participants were recruited, and all completed the study. Adherence of ≥ 80% to MGF usage inside the home was 13.3% (n = 2) pre-IPA and 20.0% (n = 3) at Week 4. Outside the home, ≥ 80% adherence to MGF was 53.3% (n = 8) pre-IPA, and 80.0% (n = 12) at Week 4. Change in scores for understanding of MGF were small, however, all participants reported that undergoing the intervention was worthwhile and beneficial.

CONCLUSIONS:

Self-reported adherence inside the home demonstrated minimal improvement after 4 weeks, however, adherence of ≥ 80% outside the home increased by 27%, with 80% of all participants reporting high adherence at Week 4. Participants rated their learnings from the experience of IPA as beneficial.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Foot Ulcer / Diabetic Foot Limits: Humans Language: En Journal: J Foot Ankle Res Year: 2022 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Foot Ulcer / Diabetic Foot Limits: Humans Language: En Journal: J Foot Ankle Res Year: 2022 Document type: Article Affiliation country: Australia